Personalized Cancer Treatment

At the forefront of personalized diagnostic cancer care today, to give cancer patients a better tomorrow.

We use nanotechnology to test the efficiency of different drugs

The drug and a barcode is encapsulated in a nanoparticle

The nanoparticle enter the cancer cell and release the drug

We collect the results and determine the efficiency of each drug

We use nanotechnology to test the efficiency of different drugs

The drug and a barcode are encapsulated in a nanoparticle

The nanoparticle enter the cancer cell and release the drug

Barcodes are analyzed inside the dead and live cells, determining the efficiency of each drug

Where we stand and our milestones

Clear regulatory path

Company owned production facility

Pre-clinical proof of concept

Secure IP

First-in-human in 2020

Discover our solution

Barcode Diagnostics provides a unique technology which assesses the efficacy of different cancer medications directly on the tumor within the patient’s body.

How we are changing the personalized cancer treatment industry

First of its kind

From a clinical perspective, our aim is to provide oncologists with a new tool that matches each patient with the most potent medicine, during the different stages of disease, to optimize cancer care.

Rapid and reliable

This technology rapidly and reliably assesses the efficacy of different cancer drugs directly on the tumor within the body, to select the optimal personalized treatment for each patient.

New personalized tool

This novel “first-of-its-kind” barcoded nanoparticle technology prescreens multiple drugs before beginning a treatment cycle. The nanoparticles are able to selectively target the tumor cells and the barcodes are used as mediators to correlate which drug is the most therapeutically efficient.

The need

Chemotherapy is the standard of care to treat various types of cancer. For each given cancer type there are a number of different chemotherapy drugs available that doctors must choose between.

 

Unfortunately, patients today often respond unreliably to their prescribed medications, leading to wasted treatment time and unnecessary toxicity for the patient, and significant added costs to the healthcare system. The oncology community is facing the key challenge of predicting patient responses to anticancer drugs to make sure that patients are treated effectively.

Careers

 

Barcode Diagnostics is seeking exceptional individuals to join our team and help lead our technology to the clinic.

Solution

Technology

Solution

Contact

Get in touch

      +972 4.6098600

      office@barcode-diagnosis.com

Barcode Diagnostics. Copyright 2019